Figure 5.

Effects of calcium channel blockers on the growth of MCF7/LCC9 cells

MCF7/LCC9 cells were grown in phenol red free IMEM supplemented with 5% CFBS. The cells were not treated (control; C) or treated with methoxyverapamil (MV; 10–100 μM) or mibefradil (MF; 1–10 μM) (panel A) or with methoxyverapamil (MV; 75 μM) and/or mibefradil (MF; 5 μM) in the absence and presence of 17β-estradiol (E2; 1 nM), 4-hydroxy tamoxifen (TAM; 1 μM), or ICI-182,780 (ICI; 100 nM) (panel B) for four days beginning on day 1. The number of cells was determined and the data are presented as fold change compared to day 1. (mean ± SEM, n ≥ 3; *, p≤0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001)